EGFR and non-small cell lung carcinoma: We attempted to constitute a predictive model for prognosis and favorable adjuvant EGFR-TKI outcome for patients with early-stage NSCLC and EGFR mutations.<h4>Results</h4>The TCR rearrangements demonstrated significant prediction for overall survival (OS).